CD47 and neoplasm: We use tumor growth data for KP1 small cell lung cancer (SCLC) allografts in immunodeficient NSG mice under RT in combination with CD47 blockade (Fig. 6 A and B), data from ref. 23, MC38-Ovalbumin (MC38-OVA) tumor in WT mice with RT and anti-CD47 or anti-SIRPα treatment (Fig. 6C), data from ref. 24, and MC38 tumor in WT mice with anti-SIRPα and high-dose radiotherapy (HRT) (Fig. 6D) experimental data from ref. 25.